rs137853229
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004260.4(RECQL4):c.2269C>T(p.Gln757*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,608,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004260.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152272Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000117 AC: 28AN: 239722Hom.: 0 AF XY: 0.000106 AC XY: 14AN XY: 131968
GnomAD4 exome AF: 0.000122 AC: 178AN: 1456590Hom.: 0 Cov.: 47 AF XY: 0.000110 AC XY: 80AN XY: 724868
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152272Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74394
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 12734318, 10319867, 25120469, 18716613, 24635570, 21418107, 27247962, 33541411) -
RECQL4: PVS1, PM3:Strong, PP1:Strong, PM2 -
Rothmund-Thomson syndrome type 2 Pathogenic:2
The RECQL4 c.2269C>T (p.Gln757Ter) change is a nonsense variant that is predicted to cause premature protein truncation or absence of protein due to nonsense-mediated decay. This variant has been reported in the homozygous or compound heterozygous state in multiple individuals with Rothmund-Thomson syndrome and RAPADILINO syndrome (PMID: 8737976, 10319867, 21418107, 25120469, 18716613, 18616953, 12734318, 24635570, 27247962). It has also been reported in the heterozygous state in an individual with osteosarcoma (PMID: 31604778). This variant has a maximum subpopulation frequency of 0.04% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as pathogenic. -
- -
Inborn genetic diseases Pathogenic:1
The c.2269C>T (p.Q757*) alteration, located in exon 14 (coding exon 14) of the RECQL4 gene, consists of a C to T substitution at nucleotide position 2269. This changes the amino acid from a glutamine (Q) to a stop codon at amino acid position 757. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from the Genome Aggregation Database (gnomAD) database, the RECQL4 c.2269C>T alteration was observed in 0.01% (32/271122) of total alleles studied, with a frequency of 0.04% (14/35144) in the Latino subpopulation. This recurrent mutation has been reported in the homozygous state and presumed in trans with other truncating alterations in patients with RECQL4-related disorders (Siitonen, 2009; Piard, 2015). Based on the available evidence, this alteration is classified as pathogenic. -
Rothmund-Thomson syndrome;C0265308:Baller-Gerold syndrome;C1849453:Rapadilino syndrome Pathogenic:1
- -
Rothmund-Thomson syndrome Pathogenic:1
- -
RECQL4-related disorder Pathogenic:1
Variant summary: RECQL4 c.2269C>T (p.Gln757X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.00012 in 239722 control chromosomes (gnomAD). c.2269C>T has been reported in the literature in multiple compound heterozygous and homozygous individuals affected with RECQL4-Related Disorders (e.g. Kitao_1999, Wang_2003, Siitonen_2009). These data indicate that the variant is very likely to be associated with disease. Three ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
- -
Baller-Gerold syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln757*) in the RECQL4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RECQL4 are known to be pathogenic (PMID: 12734318, 12952869). This variant is present in population databases (rs137853229, gnomAD 0.04%). This premature translational stop signal has been observed in individual(s) with RAPADILINO syndrome and Rothmund-Thomson syndrome (PMID: 10319867, 12734318, 18716613, 21418107, 24635570, 25120469, 27247962). ClinVar contains an entry for this variant (Variation ID: 6063). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at